Medical Developments International Limited (MDDVF) Research
Medical Developments International Limited is a global provider of essential medical solutions, engaged in both their manufacturing and distribution. The company's reach extends throughout Australia, Europe, the United States, and other international markets, with its operations divided into two primary segments: Pain Management and Respiratory. Within its respiratory division, it develops devices to assist individuals afflicted with conditions such as asthma and chronic obstructive pulmonary disease. For pain relief, a cornerstone product is Penthrox, utilized in trauma and emergency scenarios. Furthermore, Medical Developments International offers a diverse selection of medical instruments, including CPR equipment like face shield keyrings and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, and various oxygen therapy and resuscitation kits and masks. Founded in 2003, the company's main office is located in Scoresby, Australia.
Market snapshot
- Symbol
- MDDVF
- Price
- $0.37
- Day change
- 0.00%
- Market cap
- $46.8M
- P/E ratio
- -107.23x
- 52-week range
- 0.3038-0.5076
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Next earnings
- in 2 months
Peer companies
Open Medical Developments International Limited (MDDVF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.